Vault-13

VOR BIOPHARMA INC

COM · CUSIP 929033108

0 institutional holders -1 vs Q3 2025
—reported value*
0 new 0 added 0 reduced 1 sold out net sold ≈ $2.6m (-53.7k shares)

* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable.

Trends to Q4 2025

Institutional holders

Managers reporting a position, each quarter

0255075Q3 22: 49Q4 22: 59Q1 23: 61Q2 23: 72Q3 23: 60Q4 23: 61Q1 24: 70Q2 24: 72Q3 24: 55Q4 24: 53Q1 25: 46Q2 25: 35Q3 25: 1Q4 25: 00Q3 22Q2 23Q1 24Q4 24Q4 25
Numbers
QuarterHolders
Q3 202249
Q4 202259
Q1 202361
Q2 202372
Q3 202360
Q4 202361
Q1 202470
Q2 202472
Q3 202455
Q4 202453
Q1 202546
Q2 202535
Q3 20251
Q4 20250

Buyers vs sellers

Managers adding to or starting a position, vs cutting or selling out

Bought or addedCut or sold out
50050Q1 24: 32 bought or addedQ1 24: 21 cut or sold outQ2 24: 39 bought or addedQ2 24: 41 cut or sold outQ2 24Q3 24: 17 bought or addedQ3 24: 45 cut or sold outQ4 24: 19 bought or addedQ4 24: 31 cut or sold outQ4 24Q1 25: 18 bought or addedQ1 25: 33 cut or sold outQ2 25: 16 bought or addedQ2 25: 29 cut or sold outQ2 25Q3 25: 0 bought or addedQ3 25: 34 cut or sold outQ4 25: 0 bought or addedQ4 25: 1 cut or sold outQ4 25
Numbers
QuarterBought or addedCut or sold out
Q1 20243221
Q2 20243941
Q3 20241745
Q4 20241931
Q1 20251833
Q2 20251629
Q3 2025034
Q4 202501

Calls vs puts

Options held, notional value, last 4 quarters. P/C = puts ÷ calls

CallsPuts
$0$2.5m$5m$7.5m$10mQ1 25 calls: $28.0kQ1 25 puts: $7.0kQ1 25P/C 0.25Q2 25 calls: $9.8mQ2 25 puts: $610.9kQ2 25P/C 0.06Q3 25 calls: $0Q3 25 puts: $0Q3 25P/C —Q4 25 calls: $0Q4 25 puts: $0Q4 25P/C —
Numbers
QuarterCallsPutsP/C
Q1 2025$28.0k$7.0k0.25
Q2 2025$9.8m$610.9k0.06
Q3 2025$0$0—
Q4 2025$0$0—

Biggest buyers

None

Biggest sellers

JOHNSON & JOHNSON Sold out -53,732-53.7k

Major shareholders (over 5%)

Anyone who owns more than 5% of a class of the company's shares has to say so: on Schedule 13D if they may try to influence or control the company, on 13G if they're a passive investor, and update it as the stake changes. Each holder's latest filing, from 19 Dec 2024 on; percentages are of the share class, as the holder worked them out.

HolderStakeChangeShares Last filed
RA CAPITAL MANAGEMENT, L.P. 13D · may seek influence -0.1 pts · filed 2025-06-27 31.8% -0.1 pts 39.7m 2025-06-27
Reprogrammed Interchange LLC 13D · may seek influence -1.5 pts · filed 2025-10-16
Stated purposeItem 4 of Schedule 13D is hereby amended and supplemented as follows: From October 10, 2025 through October 14, 2025, Reprogrammed Interchange LLC sold the following shares of Vor Biopharma Inc. in open market transactions, resulting in a decrease in the number of shares of Common Stock beneficially owned by the Reporting Persons by more than one percent of the outstanding shares of Common Stock of the Issuer. 1. 40,983 shares on October 10, 2025, at a weighted average per share sale price of $30.9673. 2. 22,006 shares on October 13, 2025, at a weighted average per share sale price of $32.436. 3. 33,668 shares on October 14, 2025, at a weighted average per share sale price of $30.3192. Full filing
 18.6% -1.5 pts 1.3m 2025-10-16

Holders, Q4 2025

#ManagerLocationShares Value% of their portfolioChangeShares change